Annual distribution of AE reports of obinutuzumab.

<p>AE, adverse event; FAERS, Food and Drug Administration Adverse Event Reporting System; JADER, Japanese Adverse Drug Event Report.</p>

Saved in:

Bibliographic Details
Main Author:	Xiangpeng Li (1750972) (author)
Other Authors:	Haonan Liang (14207318) (author), Ping Leng (8162409) (author), Zhanqi Cao (16698596) (author)
Published:	2025
Subjects:	Medicine Cell Biology Pharmacology Biotechnology Developmental Biology Cancer Infectious Diseases unexpected adverse events study screened 7 reporting odds ratio rational clinical use patients &# 8217 cd20 monoclonal antibody 39 risk signals 15 risk signals signal mining indicate aes involved 198 2025 </ p xlink "> obinutuzumab jader databases spanning xlink "> signal strength utilizing data us food tumor indications safety assessment research design research aimed related reaction related aes registration data obinutuzumab using lymphocytic leukemia jader databases identify significant follicular lymphoma drug instruction bcpnn ), aes related
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items